← Leaderboards
Leslie Victoria Boyer
University Of Arizona
$1,600,000
Attributed
$1,600,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $400K · FY2010–17$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
FDA$1,600,000 · 1
By mechanism
R01$1,600,000 · 1
Top collaborators
No co-investigators on record.
Grant awards (7)
Phase 2 Clinical Trial of Coralmyn for Coral Snake Bite (BB-IND 13926,01/02/09)$200,000
R01 · FY2017 · FD · contact PI
Phase 2 Clinical Trial of Coralmyn for Coral Snake Bite (BB-IND 13926,01/02/09)$200,000
R01 · FY2016 · FD · contact PI
Phase 2 Clinical Trial of Coralmyn for Coral Snake Bite (BB-IND 13926,01/02/09)$150,000
R01 · FY2016 · FD · contact PI
Phase 2 Clinical Trial of Coralmyn for Coral Snake Bite (BB-IND 13926,01/02/09)$250,000
R01 · FY2015 · FD · contact PI
Phase 2 Clinical Trial of Coralmyn for Coral Snake Bite (BB-IND 13926,01/02/09)$250,000
R01 · FY2014 · FD · contact PI
Phase 2 Clinical Trial of Coralmyn for Coral Snake Bite (BB-IND 13926,01/02/09)$150,000
R01 · FY2012 · FD · contact PI
Phase 2 Clinical Trial of Coralmyn for Coral Snake Bite (BB-IND 13926,01/02/09)$400,000
R01 · FY2010 · FD · contact PI